Cargando…

Japanese and Non-Japanese Patients with Transient Ischemic Attack or Minor Stroke: A Five-Year Risk Analysis of Stroke and Vascular Events

Aims: We have previously reported 5-year follow-up data on the TIAregistry.org, an international prospective cohort in patients with transient ischemic attack (TIA) or minor stroke. We conducted a Japanese subgroup analysis because outcomes and predictors might differ according to ethnicities and re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Uchiyama, Shinichiro, Hoshino, Takao, Charles, Hugo, Kamiyama, Kenji, Nakase, Taizen, Kitagawa, Kazuo, Minematsu, Kazuo, Todo, Kenichi, Okada, Yasushi, Nakagawara, Jyoji, Nagata, Ken, Yamagami, Hiroshi, Yamaguchi, Takenori, Amarenco, Pierre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japan Atherosclerosis Society 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219541/ https://www.ncbi.nlm.nih.gov/pubmed/32938836 http://dx.doi.org/10.5551/jat.58552

Ejemplares similares

Factors Associated with Intima-Media Complex Thickness of the Common Carotid Artery in Japanese Noncardioembolic Stroke Patients with Hyperlipidemia: The J-STARS Echo Study
por: Wada, Shinichi, et al.
Publicado: (2018)

Protocol for Cilostazol Stroke Prevention Study for Antiplatelet Combination (CSPS.com): a randomized, open-label, parallel-group trial
por: Toyoda, Kazunori, et al.
Publicado: (2015)

Association of Timing for Starting Dual Antiplatelet Treatment With Cilostazol and Recurrent Stroke: A CSPS.com Trial Post Hoc Analysis
por: Toyoda, Kazunori, et al.
Publicado: (2022)

Brain Natriuretic Peptide Is a Powerful Predictor of Outcome in Stroke Patients with Atrial Fibrillation
por: Maruyama, Kenji, et al.
Publicado: (2017)

Sex Difference in the Impact of Dual Antiplatelet Therapy using Cilostazol for Secondary Stroke Prevention: A Sub-Analysis of CSPS.com
por: Hoshino, Haruhiko, et al.
Publicado: (2023)

Efficacy and Safety of Prasugrel by Stroke Subtype: A Sub-Analysis of the PRASTRO-I Randomized Controlled Trial
por: Kitazono, Takanari, et al.
Publicado: (2021)

Pravastatin Reduces the Risk of Atherothrombotic Stroke when Administered within Six Months of an Initial Stroke Event
por: Hosomi, Naohisa, et al.
Publicado: (2018)

Rivaroxaban administration after acute ischemic stroke: The RELAXED study
por: Yasaka, Masahiro, et al.
Publicado: (2019)

Cumulative Effects of LDL Cholesterol and CRP Levels on Recurrent Stroke and TIA
por: Kitagawa, Kazuo, et al.
Publicado: (2019)

Design and baseline characteristics of the Xarelto Post‐Authorization Safety & Effectiveness Study in Japanese Patients with Atrial Fibrillation (XAPASS)
por: Ogawa, Satoshi, et al.
Publicado: (2018)

Triglyceride-glucose index as a prognostic marker after ischemic stroke or transient ischemic attack: a prospective observational study
por: Hoshino, Takao, et al.
Publicado: (2022)

Real-world outcomes of rivaroxaban treatment in elderly Japanese patients with nonvalvular atrial fibrillation
por: Kitazono, Takanari, et al.
Publicado: (2019)

Reduction in High-Sensitivity C-Reactive Protein Levels in Patients with Ischemic Stroke by Statin Treatment: Hs-CRP Sub-Study in J-STARS
por: Kitagawa, Kazuo, et al.
Publicado: (2017)

Predictors of Stroke Events in Patients with Transient Ischemic Attack Attributable to Intracranial Stenotic Lesions
por: Uehara, Toshiyuki, et al.
Publicado: (2017)

Impact of body mass index on real-world outcomes of rivaroxaban treatment in Japanese patients with non-valvular atrial fibrillation
por: Murakawa, Yuji, et al.
Publicado: (2020)

Outcomes associated with under-dosing of rivaroxaban for management of non-valvular atrial fibrillation in real-world Japanese clinical settings
por: Ikeda, Takanori, et al.
Publicado: (2019)

Different Influences of Statin Treatment in Preventing At-Risk Stroke Subtypes: A Post Hoc Analysis of J-STARS
por: Hosomi, Naohisa, et al.
Publicado: (2020)

Effect of Statin on Stroke Recurrence Prevention at Different Infarction Locations: A Post Hoc Analysis of The J-STARS Study
por: Nezu, Tomohisa, et al.
Publicado: (2020)

Recurrent Stroke Incidence and Etiology in Patients with Embolic Stroke of Undetermined Source and Other Stroke Subtypes
por: Toi, Sono, et al.
Publicado: (2022)

Long-Term Effect of Pravastatin on Carotid Intima–Media Complex Thickness: The J-STARS Echo Study (Japan Statin Treatment Against Recurrent Stroke)
por: Koga, Masatoshi, et al.
Publicado: (2018)

Clinical Characteristics of Transient Ischemic Attack Patients with Atrial Fibrillation: Analyses of a Multicenter Retrospective Study
por: Hama, Yuka, et al.
Publicado: (2015)

Acute dual antiplatelet therapy for minor ischaemic stroke or transient ischaemic attack
por: Wang, Yongjun, et al.
Publicado: (2019)

Early initiation of rivaroxaban after reperfusion therapy for stroke patients with nonvalvular atrial fibrillation
por: Koge, Junpei, et al.
Publicado: (2022)

Rationale, design, and baseline features of a randomized controlled trial to assess the effects of statin for the secondary prevention of stroke: the Japan Statin Treatment Against Recurrent Stroke (J-STARS)
por: Nagai, Yoji, et al.
Publicado: (2014)

Localization of Infratentorial Lesion could Predict Patent Foramen Ovale as an Etiology in Embolic Stroke of Undetermined Source
por: Ishizuka, Kentaro, et al.
Publicado: (2022)

Effects of Pemafibrate in Patients with Stroke and Hypertriglyceridemia: Baseline Cerebral Artery Diseases and 3-Month Laboratory Outcomes
por: Hoshino, Takao, et al.
Publicado: (2022)

Eicosapentaenoic Acid as long-term secondary prevention after ischemic stroke
por: Nakase, Taizen, et al.
Publicado: (2015)

Clinical features of recurrent stroke after intracerebral hemorrhage
por: Nakase, Taizen, et al.
Publicado: (2012)

Dual Antiplatelet Therapy Using Cilostazol in Patients With Stroke and Intracranial Arterial Stenosis
por: Uchiyama, Shinichiro, et al.
Publicado: (2021)

The Japan Statin Treatment Against Recurrent Stroke (J-STARS): A Multicenter, Randomized, Open-label, Parallel-group Study
por: Hosomi, Naohisa, et al.
Publicado: (2015)

Outstanding Symptoms of Poststroke Depression during the Acute Phase of Stroke
por: Nakase, Taizen, et al.
Publicado: (2016)

Minor Stroke and Transient Ischemic Attack: Research and Practice
por: Yakhkind, Aleksandra, et al.
Publicado: (2016)

Final Results of Cilostazol-Aspirin Therapy against Recurrent Stroke with Intracranial Artery Stenosis (CATHARSIS)
por: Uchiyama, Shinichiro, et al.
Publicado: (2015)

Characteristics and Prognosis of Stroke in Living Donor Renal Transplant Recipients
por: Mizuno, Takafumi, et al.
Publicado: (2022)

Long-Term Survival after Stroke in 1.4 Million Japanese Population: Shiga Stroke and Heart Attack Registry
por: Takashima, Naoyuki, et al.
Publicado: (2020)

Free radical scavenger, edaravone, reduces the lesion size of lacunar infarction in human brain ischemic stroke
por: Nakase, Taizen, et al.
Publicado: (2011)

Hyperhomocysteinemia Increases Vascular Risk in Stroke Patients with Chronic Kidney Disease
por: Mizuno, Takafumi, et al.
Publicado: (2023)

Initial ‘TTP Map-Defect’ of Computed Tomography Perfusion as a Predictor of Hemorrhagic Transformation of Acute Ischemic Stroke
por: Shinoyama, Mizuya, et al.
Publicado: (2013)

Anti-inflammatory and antiplatelet effects of non-vitamin K antagonist oral anticoagulants in acute phase of ischemic stroke patients
por: Nakase, Taizen, et al.
Publicado: (2018)

P2Y12 Reaction Units and Clinical Outcomes in Acute Large Artery Atherosclerotic Stroke: A Multicenter Prospective Study
por: Fukuma, Kazuki, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1gfv9941knb0quk375a1drp6j3